HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert T Naismith Selected Research

ibudilast

11/2021Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
1/2021Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
1/2021Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.
1/2021Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype.
1/2018Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert T Naismith Research Topics

Disease

34Multiple Sclerosis
01/2022 - 09/2004
6Relapsing-Remitting Multiple Sclerosis
02/2022 - 11/2008
5Infections
01/2022 - 01/2014
5Atrophy
01/2021 - 01/2018
4Neuromyelitis Optica (Devic's Disease)
01/2022 - 09/2011
4Chronic Progressive Multiple Sclerosis
12/2020 - 11/2008
3Progressive Multifocal Leukoencephalopathy
02/2022 - 04/2014
2Disease Progression
12/2020 - 09/2009
2Injection Site Reaction
01/2018 - 02/2017
2Inflammation (Inflammations)
01/2015 - 08/2013
1Sudden Infant Death (SID)
02/2022
1COVID-19
01/2022
1Hypophosphatemia
02/2021
1Ganglion Cysts (Ganglion)
01/2021
1Headache (Headaches)
01/2018
1Lymphopenia (Lymphocytopenia)
01/2015
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2010
1Anemia
08/2009
1Blindness (Hysterical Blindness)
08/2009
1Hypesthesia (Numbness)
08/2009
1Leukopenia
08/2009
1Optic Nerve Diseases (Optic Neuropathy)
08/2009
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2008
1Wallerian Degeneration
11/2008
1Optic Nerve Injuries
11/2008
1Optic Neuritis (Retrobulbar Neuritis)
11/2008
1Ischemia
11/2008

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
11/2021 - 11/2008
5Natalizumab (Tysabri)FDA Link
02/2022 - 09/2009
5FumaratesIBA
01/2022 - 01/2015
5ibudilastIBA
11/2021 - 01/2018
5Interferon-betaIBA
01/2019 - 09/2009
4diroximel fumarateIBA
01/2022 - 01/2020
4GadoliniumIBA
02/2021 - 01/2015
3Dimethyl FumarateIBA
01/2022 - 01/2015
3Rituximab (Mabthera)FDA Link
01/2022 - 06/2010
3Glatiramer Acetate (Copaxone)FDA Link
10/2020 - 09/2009
3InterferonsIBA
01/2018 - 04/2014
3Immunoglobulin G (IgG)IBA
01/2015 - 07/2007
2Myelin-Oligodendrocyte GlycoproteinIBA
01/2022 - 10/2020
2ocrelizumabIBA
12/2020 - 01/2020
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2019 - 01/2018
2Retinaldehyde (Retinal)IBA
01/2018 - 11/2008
2Pharmaceutical PreparationsIBA
01/2015 - 06/2010
2ChemokinesIBA
08/2013 - 06/2010
1VaccinesIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Phosphates (Orthophosphate)IBA
02/2021
1Gadolinium DTPA (Magnevist)FDA Link
02/2021
1AntibodiesIBA
10/2020
1Interferon beta-1b (Betaseron)FDA Link
10/2020
1Cyclic NucleotidesIBA
01/2018
1Macrophage Migration-Inhibitory FactorsIBA
01/2018
1Toll-Like Receptor 4IBA
01/2018
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2018
1peginterferon beta-1aIBA
01/2018
1Alemtuzumab (Campath)FDA Link
01/2017
1Myelin Basic ProteinIBA
01/2015
1BCG VaccineFDA Link
01/2014
1MicroRNAs (MicroRNA)IBA
12/2013
1Monoclonal AntibodiesIBA
09/2011
1ProgranulinsIBA
01/2010
1CopperIBA
08/2009
1Proteins (Proteins, Gene)FDA Link
11/2008
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
09/2004

Therapy/Procedure

14Therapeutics
02/2022 - 11/2008
1Injections
02/2022
1Immunomodulation
03/2015
1Gastric Bypass (Roux-en-Y Gastric Bypass)
08/2009